-
ICD-10-CM Codes
›
-
P00-P96
›
-
P00-P04
›
-
P04-
›
-
2023 ICD-10-CM Diagnosis Code P04.40
2023 ICD-10-CM Diagnosis Code P04.40
Newborn affected by maternal use of unspecified drugs of addiction
2019 - New Code 2020 2021 2022 2023 Billable/Specific Code Code on Newborn Record
- P04.40 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
- Short description: Newborn affected by maternal use of unsp drugs of addiction
- The 2023 edition of ICD-10-CM P04.40 became effective on October 1, 2022.
- This is the American ICD-10-CM version of P04.40 - other international versions of ICD-10 P04.40 may differ.
ICD-10-CM Coding Rules
- P04.40 should be used on the newborn record - not on the maternal record.
The following code(s) above
P04.40 contain annotation back-references
Annotation Back-References
In this context, annotation back-references refer to codes that contain:
- Applicable To annotations, or
- Code Also annotations, or
- Code First annotations, or
- Excludes1 annotations, or
- Excludes2 annotations, or
- Includes annotations, or
- Note annotations, or
- Use Additional annotations
that may be applicable to
P04.40:
- P00-P96
2023 ICD-10-CM Range P00-P96
Certain conditions originating in the perinatal periodIncludes- conditions that have their origin in the fetal or perinatal period (before birth through the first 28 days after birth) even if morbidity occurs later
Note- Codes from this chapter are for use on newborn records only, never on maternal records
Type 2 Excludes- congenital malformations, deformations and chromosomal abnormalities (Q00-Q99)
- endocrine, nutritional and metabolic diseases (E00-E88)
- injury, poisoning and certain other consequences of external causes (S00-T88)
- neoplasms (C00-D49)
- tetanus neonatorum (A33)
Certain conditions originating in the perinatal period - P00-P04
2023 ICD-10-CM Range P00-P04
Newborn affected by maternal factors and by complications of pregnancy, labor, and deliveryNote- These codes are for use when the listed maternal conditions are specified as the cause of confirmed morbidity or potential morbidity which have their origin in the perinatal period (before birth through the first 28 days after birth).
Newborn affected by maternal factors and by complications of pregnancy, labor, and delivery - P04
ICD-10-CM Diagnosis Code P04
Newborn affected by noxious substances transmitted via placenta or breast milk
2016 2017 - Revised Code 2018 2019 2020 2021 2022 2023 Non-Billable/Non-Specific Code
Code First- any current condition in newborn, if applicable
Includes- nonteratogenic effects of substances transmitted via placenta
Type 2 Excludes- congenital malformations (Q00-Q99)
- encounter for observation of newborn for suspected diseases and conditions ruled out (Z05.-)
- neonatal jaundice from excessive hemolysis due to drugs or toxins transmitted from mother (P58.4)
- newborn in contact with and (suspected) exposures hazardous to health not transmitted via placenta or breast milk (Z77.-)
Newborn affected by noxious substances transmitted via placenta or breast milk
ICD-10-CM P04.40 is grouped within Diagnostic Related Group(s) (MS-DRG v40.0):
- 794 Neonate with other significant problems
Code History
- 2019 (effective 10/1/2018): New code
- 2020 (effective 10/1/2019): No change
- 2021 (effective 10/1/2020): No change
- 2022 (effective 10/1/2021): No change
- 2023 (effective 10/1/2022): No change
- Absorption
- drug NEC - see Table of Drugs and Chemicals
- Newborn (infant) (liveborn) (singleton) Z38.2
ICD-10-CM Diagnosis Code Z38.2
Single liveborn infant, unspecified as to place of birth
2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code Newborn/Neonate Dx (0 years) POA Exempt
Applicable To- Single liveborn infant NOS
ICD-10-CM Codes Adjacent To P04.40
P04.14 Newborn affected by maternal use of opiates
P04.15 Newborn affected by maternal use of antidepressants
P04.16 Newborn affected by maternal use of amphetamines
P04.17 Newborn affected by maternal use of sedative-hypnotics
P04.1A Newborn affected by maternal use of anxiolytics
P04.18 Newborn affected by other maternal medication
P04.19 Newborn affected by maternal use of unspecified medication
P04.2 Newborn affected by maternal use of tobacco
P04.3 Newborn affected by maternal use of alcohol
P04.4 Newborn affected by maternal use of drugs of addiction
P04.40
Newborn affected by maternal use of unspecified drugs of addiction
P04.41 Newborn affected by maternal use of cocaine
P04.42 Newborn affected by maternal use of hallucinogens
P04.49 Newborn affected by maternal use of other drugs of addiction
P04.5 Newborn affected by maternal use of nutritional chemical substances
P04.6 Newborn affected by maternal exposure to environmental chemical substances
P04.8 Newborn affected by other maternal noxious substances
P04.81 Newborn affected by maternal use of cannabis
P04.89 Newborn affected by other maternal noxious substances
P04.9 Newborn affected by maternal noxious substance, unspecified
P05 Disorders of newborn related to slow fetal growth and fetal malnutrition
Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.